Allergan Investors Sue Board Over Tax Tab For Exec Pay

Law360, New York (November 23, 2011, 8:04 PM EST) -- Allergan Inc.'s board of directors was hit Monday with a shareholder derivative suit alleging it issued a misleading statement asking shareholders to approve a defective executive compensation plan that cost the pharmaceutical company millions in tax benefits.

In a complaint filed in Delaware federal court, the New Jersey Building Laborers Pension Fund said Allergan's March 8 proxy statement requesting shareholder approval of the 2011 incentive plan claimed the plan would be tax-deductible if the stockholders signed off on an amendment to it.

But even with approval,...
To view the full article, register now.




Case Information

Case Title

New Jersey Building Laborers Pension Fund v. Ball et al

Case Number




Nature of Suit

Stockholders Suits


Leonard P. Stark

Date Filed

November 20, 2011

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.